| Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant … AD Joshi, RC Botham, LJ Schlein, HS Roth, A Mangraviti, A Borodovsky, ... Oncotarget 8 (46), 80124, 2017 | 34 | 2017 |
| NF-kB activation in canine cancer LJ Schlein, DH Thamm Veterinary pathology 59 (5), 724-732, 2022 | 14 | 2022 |
| Immunohistochemical characterization of procaspase-3 overexpression as a druggable target with PAC-1, a procaspase-3 activator, in canine and human brain cancers LJ Schlein, B Fadl-Alla, HC Pondenis, S Lezmi, CG Eberhart, AK LeBlanc, ... Frontiers in oncology 9, 96, 2019 | 14 | 2019 |
| In-vitro effects of taurolidine alone and in combination with mitoxantrone and/or piroxicam on canine transitional cell carcinoma B Byer, LJ Schlein, B Rose, B Séguin Canadian Journal of Veterinary Research 84 (2), 115-123, 2020 | 1 | 2020 |
| Investigating the therapeutic potential of parthenolide for hematopoietic neoplasms in dogs LJ Schlein, B Rose, A Peterson, D Thamm Cancer Research 79 (13_Supplement), 3700-3700, 2019 | 1 | 2019 |
| Parthenolide as a therapeutic for disseminated canine neoplasms LJ Schlein, SA Brill, RV Brady, KB Farrell, BJ Rose, TK Meuten, ... Journal of Pharmacology and Experimental Therapeutics 388 (3), 774-787, 2024 | | 2024 |
| Immunohistochemical evidence of NF-kB activation in canine lymphomas, histiocytic sarcomas, hemangiosarcomas, and mast cell tumors LJ Schlein, DH Thamm Veterinary Pathology 61 (1), 20-31, 2024 | | 2024 |
| Progressive inappetence, weight loss, and coughing in a 14-year-old male neutered Plott Hound CN Quinn, A Musarra, DD Dailey, LJ Schlein Journal of the American Veterinary Medical Association 261 (10), 1-3, 2023 | | 2023 |
| Overactive NF-κB Signaling as a Druggable Target and Evaluation of Parthenolide an NF-κB Inhibitor in Canine Cancer L Schlein Colorado State University, 2022 | | 2022 |
| Pathology in Practice LJ Schlein, SL Connolly, C Moran, DJ Duffy Journal of the American Veterinary Medical Association 255 (1), 67-70, 2019 | | 2019 |
| 3114 Investigating the therapeutic potential of parthenolide in the treatment of hematopoietic neoplasms in dogs LJ Schlein, A Peterson, B Rose, D Thamm Journal of Clinical and Translational Science 3 (s1), 14-15, 2019 | | 2019 |
| What is your diagnosis? Impression smear from the uropygial gland of an African Gray Parrot LJ Schlein, KL Wycislo, KR Welle, AM Barger Veterinary Clinical Pathology 48 (1), 140-142, 2019 | | 2019 |
| A neoplasm artfully unveils its origin in cytology: Karkinos emerging from the deep LJ Schlein, KL Wycislo Veterinary Clinical Pathology 47 (1), 7-8, 2018 | | 2018 |
| Evaluation of therapy for canine intracranial neoplasia using PAC-1, a novel and potent procaspase-3 activator LJ Schlein University of Illinois at Urbana-Champaign, 2017 | | 2017 |
| Magic Eye: Karkinos emerging from the deep LJ Schlein | | 2017 |
| Staining characteristics of mast cells with an aqueous Romanowsky stain in a dog with marked mastocythemia and an abdominal mass M Ramras, LJ Schlein, SD Meola, J Kazemi Veterinary Record Case Reports, e801, 0 | | |
